29
May

AstraZeneca believes the brightest future for its top oncology prospect will come through collaboration, recruiting Eli Lilly to its growing ranks of partners with eyes on kicking off a combination cancer trial.

…read more

Source: AstraZeneca adds Lilly to its stable of immuno-oncology collaborators

    

0 No comments